Bone News and Research

RSS

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

Orthovita, Inc., an orthobiologics and biosurgery company, is pleased to announce that Dr. Pierce D. Nunley, Director of the Spine Institute of Louisiana, will present his abstract, “A Comparison of Clinical Outcomes and Adjacent Level Fractures in Patients Receiving Vertebroplasty for Osteoporotic Compression Fractures Using CortossTM or PMMA: A Prospective, Randomized Trial,” at the 2009 Annual Meeting of the Congress of Neurological Surgeons (CNS).

24 Oct 2009

New trends in hospital design help health-care systems to better choreograph care

Heading to the hospital? These days, the newest member of your medical team just might be the building itself -- and it's likely to play a bigger role in your healing than you might think.

24 Oct 2009

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Researchers from Allegheny General Hospital's (AGH) Department of Orthopaedic Surgery and Center for Genomic Sciences have launched dual groundbreaking studies that may help determine the cause of two common, hard-to-treat problems experienced by patients who undergo orthopedic surgery: a joint replacement that becomes infected and a bone fracture that will not heal properly.

24 Oct 2009

Orthopedic surgeon to present latest findings on stem cells and plasma rich platelet therapy

Joseph Purita M.D., a well known Orthopedic Surgeon from Florida has announced that plans are being made with the Orthopedic Academies in Sao Paulo Brazil to present his latest findings on the use of stem cells and plasma rich platelet therapy in the treatment of certain bone and joint problems.

24 Oct 2009

Human clinical trials of TissuGlu to commence in Germany

Cohera Medical, Inc. announced today that it has received approval to begin human clinical trials of its lead product TissuGlu® in Germany. Receipt of the approval allows Cohera Medical to proceed with patient recruitment and initiation of an investigational study of the company's novel internal surgical adhesive being developed for its first intended use to adhere surgical tissues together in large flap surgeries.

24 Oct 2009

Vidacare to release results of validation study on its OnControl Bone Marrow System

Vidacare Corporation has completed an analysis and is releasing the results of a validation study on its OnControl™ Bone Marrow System, the first effort in decades to improve the safety, control, and comfort of bone marrow aspiration and biopsy procedures.

23 Oct 2009

New Category I CPT code for AspirinWorks Test Kit

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today that a new Category I Current Procedural Terminology (CPT) code has been published by the American Medical Association (AMA) for the AspirinWorks Test Kit.

23 Oct 2009

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Harvest Technologies Corp. (www.harvesttech.com) announced today that the Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to commence its BMAC Enhanced CABG Trial. This is a two phase 42-patient 'feasibility' clinical trial using the company's BMAC System to concentrate autologous bone marrow cells to treat patients with congestive heart failure undergoing treatment with coronary artery bypass grafting (CABG) Surgery.

22 Oct 2009

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

The United States Bone and Joint Decade (USBJD) today announces that as part of its 2009 Advocacy Day nearly 80 musculoskeletal patients and patient advocates from across the nation are participating in more than 175 Congressional visits. Patients and their advocates -- physicians, family members and USBJD participating partners -- are raising awareness of the huge burden that musculoskeletal conditions plays on the U.S. These conditions are some of the most costly, common, and disabling conditions to date.

22 Oct 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter ended September 30, 2009.

22 Oct 2009

SAGE announces the launch of "Therapeutic Advances in Musculoskeletal Disease"

SAGE has announced the launch of Therapeutic Advances in Musculoskeletal Disease, the latest in SAGE's highly-regarded Therapeutic Advances series.

22 Oct 2009

Laser Spine Institute acquires Aspen Back & Body

After helping thousands of patients get their lives back through minimally invasive endoscopic spinal surgery at facilities in Tampa and Scottsdale and soon Philadelphia, the Laser Spine Institute (LSI) announces their acquisition of Aspen Back & Body, LLC (ABB), extending LSI's patient care capabilities into non-surgical areas for the first time.

22 Oct 2009

The Sutter Heart Transplant Program gets recertified after an eight-month legal battle

Larry Clymer's heart was just plum wearing out. The 60-year-old Rocklin resident needed a heart transplant, and a temporary machine was implanted in his abdomen to keep his heart beating until the right heart was identified.

22 Oct 2009

Advanced BioMedical Technologies' PA Absorbable Orthopaedic Implant Screw human clinical tests completed

Advanced BioMedical Technologies Inc. announced that it has completed all 60 human clinical test cases of its PA Absorbable Orthopaedic Implant Screw according to the regulations set out by the China State Food and Drug Administration (SFDA). The actual number of test cases that have been taken in is 63.

22 Oct 2009

Study results of PTH1-34 oral parathyroid hormone presented

Emisphere Technologies, Inc. today announced study results demonstrating that a single dose of the novel oral parathyroid hormone PTH1-34, which utilizes Emisphere’s proprietary Eligen® Drug Delivery Technology and absorption-enhancer carrier molecule 5-CNAC, achieved potentially therapeutically relevant exposure and safety profiles to those of the currently available injectable formulation in healthy postmenopausal women.

22 Oct 2009

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE® (bortezomib) for Injection for patients with a common type of lymphoma. The study will examine previously untreated patients with a genomically defined subtype of lymphoma called non-germinal center B-cell-like (non-GCB) diffuse large B-cell lymphoma.

22 Oct 2009

New findings on biological cartilage may restore damaged knee joints

Damaged knee joints might one day be repaired with cartilage grown from stem cells in a laboratory, based on research by Professor Kyriacos Athanasiou, chair of the UC Davis Department of Biomedical Engineering and his colleagues.

22 Oct 2009

New partnership to create Translational Orthopedic Research Program

The creation of the Translational Orthopedic Research Program (TORP), a new partnership of Van Andel Research Institute (VARI) and its affiliate the Translational Genomics Research Institute (TGen), Spectrum Health, Orthopaedic Associates of Michigan (OAM), and the Michigan State University (MSU) College of Human Medicine, was announced today by officials of the sponsoring organizations who gathered at Van Andel Institute for the World Osteoporosis Day Summit, a meeting spotlighting local osteoporosis efforts.

22 Oct 2009

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the proprietary technologies of each.

21 Oct 2009

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Gunther von Hagens' Body Worlds 2 & The Brain made its debut at Philadelphia's Franklin Institute on October 17, and will be one of many points of interest for visitors eager to explore the area's vast array of scientific treasures.

21 Oct 2009

Bone News and Research

Orthovita to present comparative study data of its Cortoss product to polymethylmethacrylate

New trends in hospital design help health-care systems to better choreograph care

AGH Researchers to study the impact of biofilm infections on the success of orthopaedic procedures

Orthopedic surgeon to present latest findings on stem cells and plasma rich platelet therapy

Human clinical trials of TissuGlu to commence in Germany

Vidacare to release results of validation study on its OnControl Bone Marrow System

New Category I CPT code for AspirinWorks Test Kit

FDA grants IDE approval to Harvest Technologies to commence its BMAC Enhanced CABG trial

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

SAGE announces the launch of "Therapeutic Advances in Musculoskeletal Disease"

Laser Spine Institute acquires Aspen Back & Body

The Sutter Heart Transplant Program gets recertified after an eight-month legal battle

Advanced BioMedical Technologies' PA Absorbable Orthopaedic Implant Screw human clinical tests completed

Study results of PTH1-34 oral parathyroid hormone presented

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

New findings on biological cartilage may restore damaged knee joints

New partnership to create Translational Orthopedic Research Program

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Philadelphia's Franklin Institute to exhibit Gunther von Hagens' Body Worlds 2 & The Brain

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News